12 April 2016 - - The global HPV decontamination systems market revenue stood at USD 122.75m in 2015 and is expected to reach USD 220.05m by 2024, at a CAGR of 6.7% from 2016 to 2024, according to a new report from US-based market intelligence company Transparency Market Research.

HPV decontamination systems rely on microcondensation for the total elimination of pathogens from an inert environment.

These systems are used in hospitals globally, primarily for the complete disinfection of rooms that are used for patient care and also to reduce the risk of spreading to the subsequent room.

The growing prevalence of healthcare-associated infections has led to increasing use of HPV decontamination systems in hospitals and facilities worldwide.

International regulatory bodies' emphasis on sterile testing and aseptic processing is one of the major drivers of the market's growth.

Cost effectiveness with minimum downtime to business activities and operations of HPV decontaminations has also bolstered the growth of the HPV decontamination systems market.

The demand for the decontamination of laboratory-scale incubators among customers on a regular basis due to various research changes or accidental spillage, has led to increasing adoption of HPV decontamination systems in this segment.

The isolators application segment is anticipated to grow the fastest, with an expected CAGR of 7.9% during the forecast period due to its use of barrier technology to minimize the risks of contamination.

In 2015, the incubators application segment of the global HPV decontamination systems market generated revenues of USD 39.81m, which is approximately 30% of the overall HPV decontamination systems market.

Transparency Market Research is a global market intelligence company providing business information reports and services.